Income Statement

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Revenue    
Product sales, net $ 3,688,988 $ 3,569,374
Cost of products sold 1,402,285 1,368,190
Gross profit 2,286,703 2,201,184
Selling, general and administrative expenses 2,707,620 3,001,130
Research and development expenses 105,015 143,442
Total operating expenses 2,812,635 3,144,572
Loss from operations (525,932) (943,388)
Other (expenses) (1,209) (1,237)
Interest income 758 302
Loss before provision for income tax and equity in net earnings of equity investments (526,383) (944,323)
Provision for income tax (7,201) (46,834)
Loss before equity in net earnings of equity investments (533,584) (991,157)
Income (loss) in equity investments (44,401) (269,726)
Net Loss (577,985) (1,260,883)
Net loss attributable to noncontrolling interests (73,117) (510,824)
Net loss attributable to Milestone Scientific Inc. $ (504,868) $ (750,059)
Net loss per share applicable to common stockholders—    
Basic (in dollars per share) $ (0.02) $ (0.03)
Diluted (in dollars per share) $ (0.02) $ (0.03)
Weighted average shares outstanding and to be issued—    
Basic (in shares) 32,004,548 22,609,349
Diluted (in shares) 32,004,548 22,609,349
Milestone China [Member]    
Revenue    
Product sales, net $ 356,400 $ 1,000,000,000,000
Income (loss) in equity investments $ 0 $ (164,837)

Source